Apr. 2, 2025 — Lung cancer screening has the potential to catch lung cancer early and save lives -- but only if people get screened. Although lung cancer screening ... A Post-Treatment Blood ...

The FDA has granted fast-track approval to the drug telisotuzumab vedotin (sold as Emrelis) as a first-of-its-kind treatment for certain people who have non-squamous non-small-cell lung cancer.

Zongertinib conferred a clinically meaningful benefit in patients with previously treated, advanced, HER2-mutant NSCLC in a phase 1 trial.

Telisotuzumab vedotin (Teliso-V) gained FDA approval as a targeted therapy for patients with advanced non–small cell lung ...

A recent study has uncovered an unexpected connection between our diets and the progression of lung cancer, specifically a ...

The imaging agent called Cytalux works by having patients receive an infusion before surgery that causes cancerous cells to ...

The analysis showed that blood testing improved early diagnosis for a wide variety of cancers. Compared with standard cancer ...

A team of researchers has found new insight into why some lung cancer patients do not benefit from tumor-infiltrating lymphocyte, or TIL therapy. Their findings may help improve future ways to deliver ...

A team of researchers from Moffitt Cancer Center has found new insight into why some lung cancer patients do not benefit from ...

Dr. Chao H. Huang explains his skepticism regarding a recent study that linked chronic pain to significantly higher lung ...

Researchers discovered a distinct plasma biomarker signature involving proteins like CCL3 and IL-18, associated with cell death, lung injury, and platelet activation. These findings offer ...